Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,993 | 109 | 99.8% |
| Consulting Fee | $3.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $291.70 | 20 | $0 (2021) |
| Amarin Pharma Inc. | $187.24 | 11 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $176.96 | 9 | $0 (2020) |
| AbbVie Inc. | $172.36 | 8 | $0 (2021) |
| Novo Nordisk Inc | $169.30 | 11 | $0 (2021) |
| Allergan, Inc. | $136.27 | 9 | $0 (2020) |
| GlaxoSmithKline, LLC. | $128.12 | 7 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $110.66 | 2 | $0 (2019) |
| Vertiflex, Inc. | $108.98 | 1 | $0 (2018) |
| Gilead Sciences Inc | $96.69 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $352.51 | 19 | AbbVie Inc. ($172.36) |
| 2020 | $253.42 | 16 | Amarin Pharma Inc. ($79.83) |
| 2019 | $301.91 | 22 | PFIZER INC. ($91.02) |
| 2018 | $484.46 | 26 | Vertiflex, Inc. ($108.98) |
| 2017 | $603.80 | 27 | Merck Sharp & Dohme Corporation ($157.02) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2021 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Endocrinology | ||||||
| 07/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diabetes Care | ||||||
| 06/24/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardiovascular | ||||||
| 06/23/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device), REYVOW | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: GASTROINTESTINAL | ||||||
| 06/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Gastroenterology | ||||||
| 05/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Cardiovascular | ||||||
| 05/03/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 05/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular | ||||||
| 03/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Diabetes | ||||||
| 02/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Cardiovascular | ||||||
| 02/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: NEUROSCIENCE | ||||||
| 01/14/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: NEUROSCIENCE | ||||||
| 01/14/2021 | KVK-Tech, Inc. | — | Consulting Fee | Cash or cash equivalent | $3.40 | General |
| 11/23/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Cardiovascular | ||||||
| 11/06/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: Neurology | ||||||
| 10/28/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiovascular | ||||||
| 09/29/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 755 | 982 | $147,884 | $40,858 |
| 2022 | 9 | 971 | 1,174 | $143,106 | $46,499 |
| 2021 | 20 | 1,754 | 2,325 | $211,062 | $77,507 |
| 2020 | 35 | 2,339 | 3,080 | $286,253 | $153,830 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 29 | 29 | $3,625 | $3,422 | 94.4% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 13 | 14 | $5,096 | $2,844 | 55.8% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 53 | 55 | $5,500 | $2,276 | 41.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 108 | 114 | $3,990 | $1,972 | 49.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 11 | 11 | $3,300 | $1,593 | 48.3% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 50 | 58 | $2,900 | $1,328 | 45.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 82 | 89 | $3,115 | $1,133 | 36.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 63 | 63 | $2,205 | $1,088 | 49.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $2,064 | $1,032 | 50.0% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 25 | 27 | $2,187 | $954.14 | 43.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 203 | 252 | $2,520 | $743.04 | 29.5% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 16 | 16 | $1,600 | $662.03 | 41.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 45 | 46 | $5,428 | $603.52 | 11.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 48 | 49 | $2,450 | $507.15 | 20.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 25 | 25 | $750.00 | $447.65 | 59.7% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2020 | 16 | 16 | $944.00 | $447.28 | 47.4% |
| 83721 | Ldl cholesterol level | Office | 2020 | 41 | 42 | $1,050 | $432.18 | 41.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 25 | 26 | $2,080 | $427.96 | 20.6% |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 fo | Office | 2020 | 12 | 14 | $660.01 | $379.57 | 57.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 46 | 47 | $705.00 | $357.67 | 50.7% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2020 | 12 | 13 | $676.00 | $279.20 | 41.3% |
| 69209 | Removal of impacted ear wax by washing | Office | 2020 | 12 | 12 | $375.00 | $184.46 | 49.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 16 | 16 | $1,040 | $152.32 | 14.6% |
| 81002 | Urinalysis, manual test | Office | 2020 | 17 | 19 | $285.00 | $65.42 | 23.0% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 16 | 16 | $240.00 | $63.04 | 26.3% |
About Dr. Bruce Barniville, MD
Dr. Bruce Barniville, MD is a Internal Medicine healthcare provider based in Jupiter, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598758104.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Barniville, MD has received a total of $1,996 in payments from pharmaceutical and medical device companies, with $352.51 received in 2021. These payments were reported across 110 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,993).
As a Medicare-enrolled provider, Barniville has provided services to 5,819 Medicare beneficiaries, totaling 7,561 services with total Medicare billing of $318,694. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Jupiter, FL
- Active Since 08/30/2005
- Last Updated 02/19/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598758104
Products in Payments
- UBRELVY (Drug) $218.28
- Vascepa (Drug) $187.24
- BELSOMRA (Drug) $143.08
- ENTRESTO (Drug) $110.66
- Superion ISS (Device) $108.98
- PREVNAR - 13 (Biological) $104.72
- CHANTIX (Drug) $101.55
- XIFAXAN (Drug) $97.45
- Epclusa (Drug) $96.69
- Ozempic (Drug) $89.64
- ADVAIR (Drug) $66.16
- Victoza (Drug) $66.08
- SYMBICORT (Drug) $62.50
- SHINGRIX (Biological) $49.38
- LINZESS (Drug) $44.44
- MYRBETRIQ (Drug) $39.74
- VIAGRA (Drug) $39.08
- JANUVIA (Drug) $30.19
- SUPERION (Device) $29.20
- XARELTO (Drug) $23.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jupiter
Dr. Naveen Reddy, Md, MD
Internal Medicine — Payments: $157,805
Hector Florentino
Internal Medicine — Payments: $27,870
Alexandra Berger, M.d, M.D
Internal Medicine — Payments: $11,580
Kevin Green, M.d, M.D
Internal Medicine — Payments: $11,076
Dr. Avishai Mendelson, Md, MD
Internal Medicine — Payments: $9,798
Isabel Bueno, M.d, M.D
Internal Medicine — Payments: $9,448